Abstract
Objective:
To review the effects of tomato product supplementation, containing lycopene, on biomarkers of oxidative stress and carcinogenesis in human clinical trials.
Results:
Supplementation of tomato products, containing lycopene, has been shown to lower biomarkers of oxidative stress and carcinogenesis in healthy and type II diabetic patients, and prostate cancer patients, respectively. Processed tomato products like tomato juice, tomato paste, tomato puree, tomato ketchup and tomato oleoresin have been shown to provide bioavailable sources of lycopene, with consequent increases in plasma lycopene levels versus baseline. Dietary fats enhance this process and should be consumed together with food sources of lycopene. The mechanisms of action involve protection of plasma lipoproteins, lymphocyte DNA and serum proteins against oxidative damage, and anticarcinogenic effects, including reduction of prostate-specific antigen, upregulation of connexin expression and overall decrease in prostate tumor aggressiveness. There is limited in vivo data on the health benefits of lycopene alone. Most of the clinical trials with tomato products suggest a synergistic action of lycopene with other nutrients, in lowering biomarkers of oxidative stress and carcinogenesis.
Conclusions:
Consumption of processed tomato products, containing lycopene, is of significant health benefit and can be attributed to a combination of naturally occurring nutrients in tomatoes. Lycopene, the main tomato carotenoid, contributes to this effect, but its role per se remains to be investigated.
Sponsorship:
This study was supported by Human Nutrition Fund, Texas. AB wrote the first draft which was finalized by VI. VI also designed Figure 1.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Agarwal S, Rao AV (1998). Tomato lycopene and low density lipoprotein oxidation: a human dietary intervention study. Lipids 33, 981–984.
Balestrieri ML, Prisco RD, Nicolaus B, Pari P, Moriello VS, Strazzullo G et al. (2004). Lycopene in association with α-tocopherol or tomato lipophilic extracts enhances acyl-platelet-activating factor biosynthesis in endothelial cells during oxidative stress. Free Radical Biol Med 36, 1058–1067.
Boileau AC, Merchen NR, Wasson K, Atkinson CA, Erdman JW (1999). cis-Lycopene is more bioavailable than trans-lycopene in vitro and in vivo in lymph-cannulated ferrets. J Nutr 129, 1176–1181.
Boileau TWM, Boileau AC, Erdman JW (2002). Bioavailability of all-trans and cis-isomers of lycopene. Exp Biol Med 227, 914–919.
Boileau TWM, Liao Z, Kim S, Lemeshow S, Erdman Jr JW, Clinton SK (2003). Prostate carcinogenesis in N-methyl-N-nitrosourea (NMU)-testosterone-treated rats fed tomato powder, lycopene, or energy-restricted diets. J Natl Cancer Inst 95, 1578–1586.
Bowen P, Chen L, Stacewicz-Sapuntzakis M, Duncan C, Sharifi R, Ghosh L et al. (2002). Tomato sauce supplementation and prostate cancer: lycopene accumulation and modulation of biomarkers of carcinogenesis. Exp Biol Med 227, 886–893.
Britton G (1995). Structure and properties of carotenoids in relation to function. FASEB J 9, 1551–1558.
Briviba K, Schnabele K, Rechkemmer G, Bub A (2004). Supplementation of a diet low in carotenoids with tomato or carrot juice does not affect lipid peroxidation in plasma and feces of healthy men. J Nutr 134, 1081–1083.
Bub A, Watzl B, Abrahamse L, Delincee H, Adam S, Wever J et al. (2000). Moderate intervention with carotenoid-rich vegetable products reduces lipid peroxidation in men. J Nutr 130, 2200–2206.
Bub A, Barth SW, Watzl B, Briviba K, Rechkemmer G (2005). Paraoxonase 1 Q192R (PON1-192) polymorphism is associated with reduced lipid peroxidation in healthy young men on a low-carotenoid diet supplemented with tomato juice. Br J Nutr 93, 291–297.
Buiatti E, Palli D, Decarli A, Amadori D, Avellini C, Bianchi S (1989). A case–control study of gastric cancer and diet in Italy. Int J Cancer 44, 611–616.
Canene-Adams K, Campbell JK, Zaripheh S, Jeffery EH, Erdman JW (2005). The tomato as a functional food. J Nutr 135, 1226–1230.
Chen L, Stacewicz-Sapuntzakis M, Duncan C, Sharifi R, Ghosh L, van Breemen R et al. (2001). Oxidative DNA damage in prostate cancer patients consuming tomato sauce-based entrees as a whole-food intervention. J Natl Cancer Inst 93, 1872–1879.
Chopra M, O'Neill ME, Keogh N, Wortley G, Southon S, Thurnham DI (2000). Influence of increased fruit and vegetable intake on plasma and lipoprotein carotenoids and LDL oxidation in smokers and nonsmokers. Clin Chem 46, 1818–1829.
Clinton SK, Emenhiser C, Schwartz SJ, Bostwick DG, Williams AW, Moore BJ et al. (1996). cis–trans lycopene isomers, carotenoids, and retinol in the human prostate. Cancer Epidemiol Biomarkers Prev 5, 823–833.
de Lorgeril M, Salen P, Martin JL, Monjaud I, Delaye J, Mamelle N (1999). Mediterranean Diet, Traditional Risk Factors, and the Rate of Cardiovascular Complications After Myocardial Infarction: Final Report of the Lyon Diet Heart Study. Circulation 99, 779–785.
Di Mascio P, Kaiser S, Sies H (1989). Lycopene as the most efficient biological carotenoid singlet oxygen quencher. Arch Biochem Biophys 274, 532–538.
Diwadkar-Navsariwala V, Novotny JA, Gustin DM, Sosman JA, Rodvold KA, Crowell JA et al. (2003). A physiological pharmacokinetic model describing the disposition of lycopene in healthy men. J Lipid Res 44, 1927–1939.
Fuhrman B, Elis A, Aviram M (1997). Hypocholesterolemic effect of lycopene and β-carotene is related to suppression of cholesterol synthesis and augmentation of LDL receptor activity in macrophages. Biochem Biophys Res Commun 233, 658–662.
Fuhrman B, Volkova N, Rosenblat M, Aviram M (2000). Lycopene synergistically inhibits LDL oxidation in combination with vitamin E, glabridin, rosmarinic acid, carnosic acid, or garlic. Antioxidants Redox Signal 2, 491–506.
Gann PH, Ma J, Giovannucci E, Willett W, Sacks FM, Hennekens CH et al. (1999). Lower prostate cancer risk in men with elevated plasma lycopene levels: results of a prospective analysis. Cancer Res 59, 1225–1230.
Gartner C, Stahl W, Sies H (1997). Lycopene is more bioavailable from tomato paste than from fresh tomatoes. Am J Clin Nutr 66, 116–122.
Giovannucci E (1999). Tomatoes, tomato-based products, lycopene, and cancer: review of the epidemiologic literature. J Natl Cancer Inst 91, 317–331.
Giovannucci E, Rimm E, Liu Y, Stampfer M, Willett W (2002). A prospective study of tomato products, lycopene, and prostate cancer risk. J Natl Cancer Inst 94, 391–398.
Hadley CW, Clinton SK, Schwartz SJ (2003). The consumption of processed tomato products enhances plasma lycopene concentrations in association with a reduced lipoprotein sensitivity to oxidative damage. J Nutr 133, 727–732.
Hansson LE, Nyren O, Bergstrom R, Wolk A, Lindgren A, Baron J et al. (1993). Diet and risk of gastric cancer. A population-based case-control study in Sweden. Int J Cancer 55, 181–189.
Hantz HL, Young LF, Martin KR (2005). Physiologically attainable concentrations of lycopene induce mitochondrial apoptosis in LNCaP human prostate cancer cells. Exp Biol Med 230, 171–179.
Hininger IA, Meyer-Wenger A, Moser U, Wright A, Southon S, Thurnham D et al. (2001). No significant effects of lutein, lycopene or β-carotene supplementation on biological markers of oxidative stress and LDL oxidizability in healthy adult subjects. J Am Coll Nutr 20, 232–238.
Holloway DE, Yang M, Paganga G, Rice-Evans CA, Bramley PM (2000). Isomerization of dietary lycopene during assimilation and transport in plasma. Free Radical Res 32, 93–102.
Hoppe PP, Kramer K, van den Berg H, Steenge G, van Vliet T (2003). Synthetic and tomato-based lycopene have identical bioavailability in humans. Eur J Nutr 42, 272–278.
Hwang E-S, Bowen PE (2005). Effects of lycopene and tomato paste extracts on DNA and lipid oxidation in LNCaP human prostate cancer cells. Biofactors 23, 97–105.
Karas M, Amir H, Fishman D, Danilenko M, Segal S, Nahum A et al. (2000). Lycopene interferes with cell cycle progression and insulin-like growth factor I signaling in mammary cancer cells. Nutr Cancer 36, 101–111.
Kiokias S, Gordon MH (2003). Dietary supplementation with a natural carotenoid mixture decreases oxidative stress. Eur J Clin Nutr 57, 1135–1140.
Kohlmeier L, Kark JD, Gomez-Gracia E, Martin BC, Steck SE, Kardinaal AF et al. (1997). Lycopene and myocardial infarction risk in the EURAMIC Study. Am J Epidemiol 146, 618–662.
Kucuk O, Sarkar FH, Sakr W, Djurie Z, Pollak MN, Khachik F et al. (2001). Phase II randomized clinical trial of lycopene supplementation before radical prostatectomy. Cancer Epidemiol Biomarkers Prev 10, 861–868.
Kucuk O, Sarkar FH, Djuric Z, Sakr W, Pollak MN, Khachik F et al. (2002). Effects of lycopene supplementation in patients with localized prostate cancer. Exp Biol Med 227, 881–885.
La Vecchia C (1997). Mediterranean epidemiological evidence on tomatoes and the prevention of digestive tract cancers. Proc Soc Exp Biol Med 218, 125–128.
La Vecchia C, Negri E, Decarli A, D'Avanzo B, Franceschi S (1987). A case control study of diet and gastric cancer in northern Italy. Int J Cancer 40, 484–489.
Lee A, Thurnham D, Chopra M (2000). Consumption of tomato products with olive oil but not sunflower oil increases the antioxidant activity of plasma. Free Radical Biol Med 29, 1051–1055.
Levin G, Yeshurun M, Mokady S (1997). In vivo antiperoxidative effect of 9-cis β-carotene compared with that of the all-trans isomer. Nutr Cancer 27, 293–297.
Libby P (2006). Inflammation and cardiovascular disease mechanisms. Am J Clin Nutr 83, 456S–460S.
Liu C, Russell RM, Wang X-D (2006). Lycopene supplementation prevents smoke-induced changes in p53, p53 phosphorylation, cell proliferation, and apoptosis in the gastric mucosa of ferrets. J Nutr 136, 106–111.
Obermuller-Jevic UC, Olano-Martin E, Corbacho AM, Eiserich JP, van der Vliet A, Valacchi G et al. (2003). Lycopene inhibits the growth of normal human prostate epithelial cells in vitro. J Nutr 133, 3356–3360.
Pool-Zobel BL, Bub A, Muller H, Wollowski I, Rechkemmer G (1997). Consumption of vegetables reduces genetic damage in humans: first result of a human intervention trial with carotenoid-rich foods. Carcinogenesis 18, 1847–1850.
Porrini M, Riso P, Testolin G (1998). Absorption of lycopene from single or daily portions of raw and processed tomato. Br J Nutr 80, 353–361.
Porrini M, Riso P (2000). Lymphocyte lycopene concentration and DNA protection from oxidative damage is increased in women after a short period of tomato consumption 130, 189–192.
Porrini M, Riso P, Oriani G (2002). Spinach and tomato consumption increases lymphocyte DNA resistance to oxidative stress but this is not related to cell carotenoid concentrations. Eur J Nutr 41, 95–100.
Porrini M, Riso P, Brusamolino A, Berti C, Guarnieri S, Visioli F (2005). Daily intake of a formulated tomato drink affects carotenoid plasma and lymphocyte concentrations and improves cellular antioxidant protection. Br J Nutr 93, 93–99.
Rao AV, Agarwal S (1998). Bioavailability and in vivo antioxidant properties of lycopene from tomato products and their possible role in the prevention of cancer. Nutr Cancer 31, 199–203.
Rao AV, Agarwal S (2000). Role of antioxidant lycopene in cancer and heart disease. J Am Coll Nutr 19, 563–569.
Rao AV (2002). Lycopene, tomatoes, and the prevention of coronary heart disease. Exp Biol Med 227, 908–913.
Rao AV, Shen H (2002). Effect of low dose lycopene intake on lycopene bioavailability and oxidative stress. Nutr Res 22, 1125–1131.
Rao AV (2004). Processed tomato products as a source of dietary lycopene: bioavailability and antioxidant properties. Can J Diet Pract Res 65, 161–165.
Reboul E, Borel P, Mikail C, Abou L, Charbonnier M, Caris-Veyrat C et al. (2005). Enrichment of tomato paste with 6% tomato peel increases lycopene and β-carotene bioavailability in men. J Nutr 135, 790–794.
Re R, Fraser PD, Long M, Bramley PM, Rice-Evans C (2001). Isomerization of lycopene in the gastric milieu. Biochem Biophys Res Commun 281, 576–581.
Richelle M, Bortlik K, Liardet S, Hager C, Lambelet P, Baur M et al. (2002). A food-based formulation provides lycopene with the same bioavailability to humans as that from tomato paste. J Nutr 132, 404–408.
Riso P, Pinder A, Santangelo A, Porrini M (1999). Does tomato consumption effectively increase the resistance of lymphocyte DNA to oxidative damage? Am J Clin Nutr 69, 712–718.
Riso P, Visioli F, Erba D, Testolin G, Porrini M (2004). Lycopene and vitamin C concentrations increased in plasma and lymphocytes after tomato intake. Effects on cellular antioxidant protection. Eur J Clin Nutr 58, 1350–1358.
Rissanen T, Voutilainen S, Nyyssonen K, Salonon J, Kaplan G, Salonen J (2003). Serum lycopene concentration and carotid atherosclerosis: the Kuopio Ischemic Heart Disease Risk Factor Study. Am J Clin Nutr 77, 133–138.
Sesso HD, Liu S, Gaziano JM, Buring JE (2003). Dietary lycopene, tomato-based food products and cardiovascular disease in women. J Nutr 133, 2336–2341.
Siler U, Barella L, Spitzer V, Schnorr J, Lein M, Goralczyk R et al. (2004). Lycopene and vitamin E interfere with autocrine/paracrine loops in the Dunning prostate cancer model. FASEB J (published online April 14, 2004).
Stahl W, von Laar J, Martin HD, Emmerich T, Sies H (2000). Stimulation of gap junctional communication: comparison of acyclo-retinoic acid and lycopene. Arch Biochem Biophys 373, 271–274.
Unlu NZ, Bohn T, Clinton SK, Schwartz SJ (2005). Carotenoid absorption from salad and salsa by humans is enhanced by the addition of avocado or avocado oil. J Nutr 135, 431–436.
Upritchard JE, Sutherland WHF, Mann JI (2000). Effect of supplementation with tomato juice, vitamin E, and vitamin C on LDL oxidation and products of inflammatory activity in Type 2 diabetes. Diabetes Care 23, 733–738.
Vine AL, Bertram JS (2005). Upregulation of connexin 43 by retinoids but not by non- provitamin A carotenoids requires RARs. Nutr Cancer 52, 105–113.
Visioli F, Riso P, Grande S, Galli C, Porrini M (2003). Protective activity of tomato products on in vivo markers of lipid oxidation. Eur J Nutr 42, 201–206.
Wu K, Schwartz SJ, Platz EA, Clinton SK, Erdman JW, Ferruzzi MG et al. (2003). Variations in plasma lycopene and specific isomers over time in a cohort of US men. J Nutr 133, 1930–1936.
Zhao X, Aldini G, Johnson EJ, Rasmussen H, Kraemer K, Woolf H et al. (2006). Modification of lymphocyte DNA damage by carotenoid supplementation in postmenopausal women. Am J Clin Nutr 83, 163–169.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Basu, A., Imrhan, V. Tomatoes versus lycopene in oxidative stress and carcinogenesis: conclusions from clinical trials. Eur J Clin Nutr 61, 295–303 (2007). https://doi.org/10.1038/sj.ejcn.1602510
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.ejcn.1602510
Keywords
This article is cited by
-
Edible flowers of India as alternate source of high quantity of lycopene
Vegetos (2023)
-
Lipidic extract of whole tomato reduces hyperplasia, oxidative stress and inflammation on testosterone-induced BPH in obese rats
International Urology and Nephrology (2022)
-
Tomato powder is more effective than lycopene to alleviate exercise-induced lipid peroxidation in well-trained male athletes: randomized, double-blinded cross-over study
Journal of the International Society of Sports Nutrition (2021)
-
Radiation mitigating activities of Psidium guajava L. against whole-body X-ray-induced damages in albino Wistar rat model
3 Biotech (2020)
-
Watermelon Juice: a Novel Functional Food to Increase Circulating Lycopene in Older Adult Women
Plant Foods for Human Nutrition (2019)